Antibiotic resistance profile of common uropathogens during COVID-19 pandemic: hospital based epidemiologic study.
BMC Microbiol
; 23(1): 28, 2023 01 25.
Article
in English
| MEDLINE | ID: covidwho-2214528
ABSTRACT
BACKGROUND:
Antimicrobial resistance has a direct impact on the ability to treat common infections, and this was worsened during the COVID-19 pandemic. Worldwide surveillance studies are lacking and resistance rates vary spatially, so frequent local surveillance reports are required to guide antimicrobial stewardship efforts. This study aims to report our common local uropathogens and their antibiogram profiles in our community during the COVID era.METHODS:
A retrospective study included patients referred to our urology units with urine culture and sensitivity. All bacterial strains were identified, and their antibiotic susceptibilities were tested.RESULTS:
Out of 2581 urine culture results recruited, 30% showed microbiological proof of infection. The majority, 486 (63.4%), were isolated from females. The most frequent isolates were Escherichia coli (44.4%) and Staphylococcus aureus (17.8%). The resistance rates ranged from 26.9 to 79.7%. Piperacillin-tazobactam antibiotic had the lowest resistance rate. The multi-drug resistance pattern was recorded in 181 (23.9%) of the isolates; 159/597 (26.6%) Gram-negative and 22/160 (13.8%) Gram-positive isolates.CONCLUSIONS:
Alarming rates of antimicrobial resistance were detected, which stresses the significance of following infection control policies and establishing national antimicrobial stewardship standards.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Urinary Tract Infections
/
COVID-19
Type of study:
Observational study
Limits:
Female
/
Humans
Language:
English
Journal:
BMC Microbiol
Journal subject:
Microbiology
Year:
2023
Document Type:
Article
Affiliation country:
S12866-023-02773-5
Similar
MEDLINE
...
LILACS
LIS